Financhill
Sell
48

STOK Quote, Financials, Valuation and Earnings

Last price:
$11.49
Seasonality move :
-11.44%
Day range:
$11.32 - $11.86
52-week range:
$5.35 - $16.15
Dividend yield:
0%
P/E ratio:
14.62x
P/S ratio:
3.46x
P/B ratio:
1.80x
Volume:
403.4K
Avg. volume:
571.4K
1-year change:
-9.98%
Market cap:
$630.6M
Revenue:
$36.6M
EPS (TTM):
$0.79

Earnings Data

Next earnings date for STOK
Aug 07
2025
Most recent earnings per share
$1.90
Beat by $1.99
(May 13/2025)
Consensus Estimate
-$0.09
(May 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

STOK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $4.7M -- -- -$0.61 --
08/07/2025 Q2 $4.7M -- -- -$0.49 --
05/13/2025 Q1 $31.5M $158.6M $1.90 -$0.09 $1.99
03/18/2025 Q4 $4.3M $22.6M -$0.18 -$0.53 $0.35
11/05/2024 Q3 $3.6M $4.9M -$0.47 -$0.54 $0.07
08/07/2024 Q2 $3.3M $4.8M -$0.46 -$0.56 $0.10
05/06/2024 Q1 $3.2M $4.2M -$0.57 -$0.61 $0.04
03/25/2024 Q4 $3.2M $2.8M -$0.60 -$0.63 $0.03
11/07/2023 Q3 -- -- -$0.55 -$0.65 $0.10
08/07/2023 Q2 -- -- -$0.69 -$0.66 -$0.03
05/04/2023 Q1 -- -- -$0.53 -$0.72 $0.19
03/10/2023 Q4 -- -- -$0.65 -$0.71 $0.06
11/14/2022 Q3 -- -- -$0.66 -$0.68 $0.02
08/08/2022 Q2 -- -- -$0.63 -$0.69 $0.06
05/10/2022 Q1 -- -- -$0.66 $0.13 -$0.79
03/10/2022 Q4 -- -- -$0.66 -$0.61 -$0.05
11/08/2021 Q3 -- -- -$0.61 -$0.55 -$0.06
08/10/2021 Q2 -- -- -$0.60 -$0.46 -$0.14
05/10/2021 Q1 -- -- -$0.46 -$0.44 -$0.02
03/09/2021 Q4 -- -- -$0.42 -$0.42 $0.00
11/12/2020 Q3 -- -- -$0.41 -$0.43 $0.02
08/10/2020 Q2 -- -- -$0.39 -$0.36 -$0.03
05/15/2020 Q1 -- -- -$0.34 -$0.37 $0.03
03/23/2020 Q4 -- -- -$0.31 -$0.30 -$0.01
11/12/2019 Q3 -- -- -$0.26 -$0.28 $0.02
08/14/2019 Q2 -- -- -$1.54 -$1.63 $0.09

Stoke Therapeutics Earnings Questions

  • How Much did Stoke Therapeutics Generate in Revenue Last Quarter?

    Stoke Therapeutics reported $158.6M worth of top line sales in its most recent quarter.

  • Did Stoke Therapeutics Beat Earnings Last Quarter?

    Stoke Therapeutics announced earnings per share of $1.90 which represents a beat of analyst forecast a -$0.09 per share.

  • Is Stoke Therapeutics Profitable?

    Stoke Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Stoke Therapeutics EPS Next Year?

    Stoke Therapeutics's earnings are forecast to decrease from -$1.65 per share to -$2.02 per share next year representing a decrease of -18.46%.

  • When is Stoke Therapeutics's Earnings Date?

    Stoke Therapeutics's next earnings date is August 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Robinhood Stock Keep Going Up?
Will Robinhood Stock Keep Going Up?

Commission-free online brokerage Robinhood (NASDAQ:HOOD) has served up massive gains…

Where Will Hershey Stock Be In 1 Year?
Where Will Hershey Stock Be In 1 Year?

Chocolate stocks used to be the epitome of sleepy stability,…

Where Will KNOT Stock Be In 1 Year?
Where Will KNOT Stock Be In 1 Year?

In the case of KNOT Offshore Partners (KNOP), most headlines…

Stock Ideas

Buy
63
Is NVDA Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 53x

Buy
60
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 42x

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
92
BGL alert for Jul 3

Blue Gold [BGL] is down 20.3% over the past day.

Sell
18
CNC alert for Jul 3

Centene [CNC] is down 1.3% over the past day.

Sell
12
MOH alert for Jul 3

Molina Healthcare [MOH] is up 0.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock